Conditional PPARγ knockout from cardiomyocytes of adult mice impairs myocardial fatty acid utilization and cardiac function

American Journal of Translational Research

Volumn 3, Issue 1, 2011, Pages 61-72

  Luo, Jinwen ^a,b   Wu, Sijie ^a,b   Liu, Jian ^a   Li, Yuquan ^c   Yang, Huan ^a   Kim, Teayoun ^a   Zhelyabovska, Olga ^a   Ding, Guoliang ^d   Zhou, Yiqun ^a   Yang, Yifeng ^b   Yang, Qinglin ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac function; Fatty acid metabolism; Fatty acid utilization; PPAR

Indexed keywords

ACTIN; CARNITINE PALMITOYLTRANSFERASE I; CD36 ANTIGEN; COPPER ZINC SUPEROXIDE DISMUTASE; CRE RECOMBINASE; FATTY ACID; FATTY ACID BINDING PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TAMOXIFEN;

ANIMAL CELL; ARTICLE; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; GENE EXPRESSION; GENE TARGETING; HEART CONTRACTION; HEART FUNCTION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; KNOCKOUT MOUSE; LIPID METABOLISM; LOXP SITE; MALE; METABOLIC REGULATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

MUS;

EID: 78650211955     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Aarenstrup L, Flindt EN, Otkjaer K, Kirkegaard M, Andersen JS and Kristiansen K. HDAC activity is required for p65/RelA-dependent repression of PPARdelta-mediated transactivation in human keratinocytes. J Invest Dermatol 2008; 128: 1095-1106.
2. Issemann I and Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990; 347: 645-650.
3. Carter ME, Gulick T, Moore DD and Kelly DP. A pleiotropic element in the medium-chain acyl coenzyme A dehydrogenase gene promoter mediates transcriptional regulation by multiple nuclear receptor transcription factors and defines novel receptor-DNA binding motifs. Mol Cell Biol 1994; 14: 4360-4372.
4. Clabby ML, Robison TA, Quigley HL, Wilson DB and Kelly DP. RXRalpha represses GATA-4-mediated transcription via a retinoid-dependent Interaction with the cardiac-enriched repressor FOG-2. J Biol Chem 2002;
5. Huss JM, Levy FH and Kelly DP. Hypoxia inhibits the peroxisome proliferator-activated receptor alpha/retinoid X receptor gene regulatory pathway in cardiac myocytes: a mechanism for O2-dependent modulation of mitochondrial fatty acid oxidation. J Biol Chem 2001; 276: 27605-27612.
6. Iwaki M, Matsuda M, Maeda N, Funahashi T, Matsuzawa Y, Makishima M and Shimomura I. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 2003; 52: 1655-1663.
7. Keller H, Dreyer C, Medin J, Mahfoudi A, Ozato K and Wahli W. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc Natl Acad Sci U S A 1993; 90: 2160-2164.
8. Kliewer SA, Xu HE, Lambert MH and Willson TM. Peroxisome proliferator-activated receptors: from genes to physiology. Recent Prog Horm Res 2001; 56: 239-263.
9. Mukherjee R, Jow L, Croston GE and Paterniti JR, Jr. Identification, characterization, and tissue distribution of human peroxisome proliferatoractivated receptor (PPAR) isoforms PPARgamma2 versus PPARgamma1 and activation with retinoid X receptor agonists and antagonists. J Biol Chem 1997; 272: 8071-8076.
10. Osorio JC, Stanley WC, Linke A, Castellari M, Diep QN, Panchal AR, Hintze TH, Lopaschuk GD and Recchia FA. Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-alpha in pacing-induced heart failure. Circulation 2002; 106: 606-612.
11. Schlezinger JJ, Jensen BA, Mann KK, Ryu HY and Sherr DH. Peroxisome proliferator-activated receptor gamma-mediated NF-kappa B activation and apoptosis in pre-B cells. J Immunol 2002; 169: 6831-6841.
12. Schoonjans K, Staels B and Auwerx J. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta 1996; 1302: 93-109.
13. Steinmetz M, Quentin T, Poppe A, Paul T and Jux C. Changes in expression levels of genes involved in fatty acid metabolism: upregulation of all three members of the PPAR family (alpha, gamma, delta) and the newly described adiponectin receptor 2, but not adiponectin receptor 1 during neonatal cardiac development of the rat. Basic Res Cardiol 2005; 100: 263-269.
14. Zhang Y, Repa JJ, Gauthier K and Mangelsdorf DJ. Regulation of lipoprotein lipase by the oxysterol receptors, LXRalpha and LXRbeta. J Biol Chem 2001; 276: 43018-43024.
15. Braissant O, Foufelle F, Scotto C, Dauca M and Wahli W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 1996; 137: 354-366.
16. Djouadi F, Weinheimer CJ, Saffitz JE, Pitchford C, Bastin J, Gonzalez FJ and Kelly DP. A genderrelated defect in lipid metabolism and glucose homeostasis in peroxisome proliferator- acti vated receptor alpha- deficient mice. J Clin Invest 1998; 102: 1083-1091.
17. Leone TC, Weinheimer CJ and Kelly DP. A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci U S A 1999; 96: 7473-7478.
18. Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B and Wahli W. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 1999; 103: 1489-1498.
19. Gilde AJ, van der Lee KA, Willemsen PH, Chinetti G, van der Leij FR, van der Vusse GJ, Staels B and van Bilsen M. Peroxisome proliferatoractivated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism. Circ Res 2003; 92: 518-524.
20. Cheng L, Ding G, Qin Q, Huang Y, Lewis W, He N, Evans RM, Schneider MD, Brako FA, Xiao Y, Chen YE and Yang Q. Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat Med 2004; 10: 1245-1250.
21. Cheng L, Ding G, Qin Q, Xiao Y, Woods D, Chen YE and Yang Q. Peroxisome proliferator-activated receptor delta activates fatty acid oxidation in cultured neonatal and adult cardiomyocytes. Biochem Biophys Res Commun 2004; 313: 277-286.
22. Li Y, Yin R, Liu J, Wang P, Wu S, Luo J, Zhelyabovska O and Yang Q. Peroxisome proliferatoractivated receptor delta regulates mitofusin 2 expression in the heart. J Mol Cell Cardiol 2009; 46: 876-882.
23. Li Y, Cheng L, Qin Q, Liu J, Lo WK, Brako LA and Yang Q. High-fat feeding in cardiomyocyterestricted PPARdelta knockout mice leads to cardiac overexpression of lipid metabolic genes but fails to rescue cardiac phenotypes. J Mol Cell Cardiol 2009; 47: 536-543.
24. Burkart EM, Sambandam N, Han X, Gross RW, Courtois M, Gierasch CM, Shoghi K, Welch MJ and Kelly DP. Nuclear receptors PPARbeta/delta and PPARalpha direct distinct metabolic regulatory programs in the mouse heart. J Clin Invest 2007; 117: 3930-3939.
25. Son NH, Park TS, Yamashita H, Yokoyama M, Huggins LA, Okajima K, Homma S, Szabolcs MJ, Huang LS and Goldberg IJ. Cardiomyocyte expression of PPARgamma leads to cardiac dysfunction in mice. J Clin Invest 2007; 117: 2791-2801.
26. Ding G, Fu M, Qin Q, Lewis W, Kim HW, Fukai T, Bacanamwo M, Chen YE, Schneider MD, Mangelsdorf DJ, Evans RM and Yang Q. Cardiac peroxisome proliferator-activated receptor gamma is essential in protecting cardiomyocytes from oxidative damage. Cardiovasc Res 2007; 76: 269-279.
27. Wang P, Liu J, Li Y, Wu S, Luo J, Yang H, Subbiah R, Chatham J, Zhelyabovska O and Yang Q. Peroxisome proliferator-activated receptor {delta} is an essential transcriptional regulator for mitochondrial protection and biogenesis in adult heart. Circ Res 2010; 106: 911-919.
28. Mehrabi MR, Thalhammer T, Haslmayer P, Glogar HD, Wieselthaler G, Humpeler S, Marktl W and Ekmekcioglu C. The peroxisome proliferator- activated receptor gamma (PPARgamma) is highly expressed in human heart ventricles. Biomed Pharmacother 2002; 56: 407-410.
29. Krishnan J, Suter M, Windak R, Krebs T, Felley A, Montessuit C, Tokarska-Schlattner M, Aasum E, Bogdanova A, Perriard E, Perriard JC, Larsen T, Pedrazzini T and Krek W. Activation of a HIF1alpha-PPARgamma axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy. Cell Metab 2009; 9: 512-524.
30. Shiomi T, Tsutsui H, Hayashidani S, Suematsu N, Ikeuchi M, Wen J, Ishibashi M, Kubota T, Egashira K and Takeshita A. Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 2002; 106: 3126-3132.
31. Asakawa M, Takano H, Nagai T, Uozumi H, Hasegawa H, Kubota N, Saito T, Masuda Y, Kadowaki T and Komuro I. Peroxisome proliferatoractivated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo. Circulation 2002; 105: 1240-1246.
32. Yamamoto K, Ohki R, Lee RT, Ikeda U and Shimada K. Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes. Circulation 2001; 104: 1670-1675.
33. Duan SZ, Ivashchenko CY, Russell MW, Milstone DS and Mortensen RM. Cardiomyocyte-specific knockout and agonist of peroxisome proliferatoractivated receptor-gamma both induce cardiac hypertrophy in mice. Circ Res 2005; 97: 372-379.
34. Caglayan E, Stauber B, Collins AR, Lyon CJ, Yin F, Liu J, Rosenkranz S, Erdmann E, Peterson LE, Ross RS, Tangirala RK and Hsueh WA. Differential roles of cardiomyocyte and macrophage peroxisome proliferator-activated receptor gamma in cardiac fibrosis. Diabetes 2008; 57: 2470-2479.
35. Ding G, Cheng L, Qin Q, Frontin S and Yang Q. PPARdelta modulates lipopolysaccharideinduced TNFalpha inflammation signaling in cultured cardiomyocytes. J Mol Cell Cardiol 2006; 40: 821-828.